Screener
USANA Health Sciences USNA EPS (Diluted)
Discontinued — last reported Q1 '26
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by USANA Health Sciences in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: USANA Health Sciences’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:35 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000896264-26-000034
| Line item | Three months ended / April 4,2026 | Three months ended / March 29,2025 |
|---|---|---|
| Net earnings attributable to USANA | $7,515 | $9,402 |
| Earnings per common share attributable to USANA | ||
| Basic | $0.41 | $0.49 |
| Diluted | $0.41 | $0.49 |
| Weighted average common shares outstanding | ||
| Basic | 18,398 | 19,049 |
| Diluted | 18,411 | 19,085 |
| Comprehensive income (loss): |
Item 1. FINANCIAL STATEMENTS
FAQ
- What is USANA Health Sciences's EPS (diluted)?
- USANA Health Sciences (USNA) reported EPS (diluted) of $0.41 in Q1 2026.
- How has USANA Health Sciences's EPS (diluted) changed year-over-year?
- USANA Health Sciences's EPS (diluted) decreased by 16.3% year-over-year, from $0.49 to $0.41.
- What is the long-term trend for USANA Health Sciences's EPS (diluted)?
- Over 2 years (2022 to 2024), USANA Health Sciences's EPS (diluted) has grown at a -21.9% compound annual growth rate (CAGR), from $3.59 to $2.19.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about USANA Health Sciences's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude